Provided by Tiger Fintech (Singapore) Pte. Ltd.

Capricor Therapeutics

14.23
+1.057.97%
Post-market: 14.590.3600+2.53%19:59 EDT
Volume:2.51M
Turnover:35.06M
Market Cap:650.42M
PE:-10.02
High:14.35
Open:13.26
Low:12.80
Close:13.18
Loading ...

Press Release: Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13

Dow Jones
·
06 May

Sector Update: Health Care Stocks Lower Monday Afternoon

MT Newswires Live
·
06 May

Capricor Therapeutics Shares Fall as FDA Plans Panel Review for Duchenne Treatment

MT Newswires Live
·
06 May

BUZZ-U.S. STOCKS ON THE MOVE-Airline stocks, Wendy's, Skechers

Reuters
·
05 May

BUZZ-Capricor falls after FDA to hold advisory meeting for cell therapy

Reuters
·
05 May

Analysts Are Bullish on These Healthcare Stocks: Capricor Therapeutics (CAPR), Rezolute (RZLT)

TIPRANKS
·
05 May

Capricor share weakness unwarranted, says H.C. Wainwright

TIPRANKS
·
05 May

Capricor Therapeutics Shares Fall 7.2% After FDA to Hold Advisory Committee Meeting for Co's Experimental Cell Therapy

THOMSON REUTERS
·
05 May

Capricor Therapeutics Shares Fall 8.1% Premarket After FDA to Hold Advisory Committee Meeting for Co's Experimental Cell Therapy

THOMSON REUTERS
·
05 May

Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting With FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

THOMSON REUTERS
·
05 May

Capricor Therapeutics Inc - Deramiocel on Track for Pdufa Action Date August 31, 2025

THOMSON REUTERS
·
05 May

Capricor Therapeutics Inc - FDA to Hold Advisory Committee Meeting for Deramiocel

THOMSON REUTERS
·
05 May

Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

GlobeNewswire
·
05 May

Piper Sandler Sticks to Its Buy Rating for Capricor Therapeutics (CAPR)

TIPRANKS
·
25 Apr

Capricor Therapeutics Inc (CAPR) Q4 2024 Earnings Call Highlights: Navigating Financial ...

GuruFocus.com
·
22 Apr

OmniAb Announces Two New Appointments to its Board of Directors

Business Wire
·
21 Apr

When Will Capricor Therapeutics, Inc. (NASDAQ:CAPR) Become Profitable?

Simply Wall St.
·
17 Apr

Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day

GlobeNewswire
·
01 Apr

High Growth Tech Stocks In The US Market With Promising Potential

Simply Wall St.
·
28 Mar

Capricor Therapeutics Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
21 Mar